Clinical Trial Update: Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban [Phase 3]

View source ↗

Summary

Phase 3 trial comparing danaparoid to argatroban in heparin-induced thrombocytopenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)
• Danaparoid (danaparoid)

Snippet

Sponsor: Aspen Global Incorporated | Conditions: Heparin-induced Thrombocytopenia | Phase 3 | Status: TERMINATED